Evidence map›Paper›PMID 33456480›Full record

ReviewDrugs in context2021

Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries.

George Kassianos, Ashis Banerjee, Florence Baron-Papillon, Alan W Hampson, Janet E McElhaney, Allison McGeer, Thierry Rigoine de Fougerolles, Mitch Rothholz, Holly Seale, Litjen J Tan and 2 more

Abstract readReview
In one paragraph

Review in Drugs in context, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

George KassianosRoyal College of General Practitioners, London, UK.
Ashis BanerjeePublic Health England, London, UK.
Florence Baron-PapillonSanofi Pasteur, Lyon, France.
Alan W HampsonFederation University, Mount Helen, VIC, Australia.
Janet E McElhaneyHealth Sciences North Research Institute, Sudbury, ON, Canada.
Allison McGeerDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Thierry Rigoine de FougerollesCorporate Value Associates, Paris, France.
Mitch RothholzAmerican Pharmacists Association, Washington, DC, USA.
Holly SealeSchool of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia.
Litjen J TanImmunization Action Coalition, Saint Paul, MN, USA.
Angus ThomsonSanofi Pasteur, Lyon, France.
Olivier VitouxCorporate Value Associates, Paris, France.

Funding

High-resolution single cell profiling of vaccine responsiveness in the elderlyR01AI142086 · NIAID · JACKSON LABORATORY · PI UCAR, DUYGU · 2019 to 2023
$2.9M
Immune Response to High-Dose vs. Standard Dose Influenza VaccineR01AG048023 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KUCHEL, GEORGE A, MCELHANEY, JANET E. · 2014 to 2018
$2.1M
NIAID NIH HHS R01 AI142086NIA NIH HHS R01 AG048023
6 · The paper itself

Abstract

backgroundMany countries consistently fail to achieve the target influenza vaccine coverage rate (VCR) of 75% for populations at risk of complications, recommended by the World Health Organization and European Council. We aimed to identify factors for achieving a high VCR in the scope of four benchmark countries with high influenza VCRs: Australia, Canada, UK and USA.

methodsPublicly available evidence was first reviewed at a global level and then for each of the four countries. Semi-structured interviews were then conducted with stakeholders meeting predefined criteria. Descriptive cluster analyses were performed to identify key factors and pillars for establishing and maintaining high VCRs.

resultsNo single factor led to a high VCR, and each benchmark country used a different combination of tailored approaches to achieve a high vaccine coverage. In each country, specific triggers were important to stimulate changes that led to improved vaccine coverage. A total of 42 key factors for a successful influenza vaccination programme were identified and clustered into five pillars: (1) Health Authority accountability and strengths of the influenza programme, (2) facilitated access to vaccination, (3) healthcare professional accountability and engagement, (4) awareness of the burden and severity of disease and (5) belief in influenza vaccination benefit. Each benchmark country has implemented multiple factors from each pillar.

conclusionA wide range of factors were identified from an evaluation of four high-performing benchmark countries, classified into five pillars, thus providing a basis for countries with lower VCRs to tailor their own particular solutions to improve their influenza VCR.

Indexed as

benchmarkinfluenza vaccinevaccine coverage rate

Identifiers

PMID33456480
PMCPMC7789908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.